NCT06206395View on ClinicalTrials.gov

Role of Multi-modality Imaging in the Assessment of Chemotherapy Related Cardiac Dysfunction Among Cancer Patients

Not yet recruitingOBSERVATIONAL

Enrollment

190

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

March 1, 2025

Study Completion Date

May 1, 2025

Conditions

2D Speckle Tracking EchocardiographyBreast CancerCardiac Magnetic Resonance

Interventions

DEVICE

Two dimensions speckle tracking and three dimension echocardiography and cardiac magnetic resonance imaging

"2D speckle tracking echo will be performed before chemotherapy and after mid-cycle and after completion of treatment.~3D echo and CMR will be performed before and after chemotherapy treatment."

Trial Locations (1)

71515

Assiut University-Cardiovascular department, Asyut

All Listed Sponsors

lead

Assiut University

OTHER

NCT06206395 - Role of Multi-modality Imaging in the Assessment of Chemotherapy Related Cardiac Dysfunction Among Cancer Patients | Biotech Hunter | Biotech Hunter